HomeCompareCALZF vs PEP

CALZF vs PEP: Dividend Comparison 2026

CALZF yields 333.33% · PEP yields 3.63%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CALZF wins by $3112.11M in total portfolio value
10 years
CALZF
CALZF
● Live price
333.33%
Share price
$0.60
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$3112.25M
Annual income
$1,957,209,378.70
Full CALZF calculator →
PEP
PepsiCo Inc.
● Live price
3.63%
Share price
$156.82
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141.9K
Annual income
$61,875.67
Full PEP calculator →

Portfolio growth — CALZF vs PEP

📍 CALZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCALZFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CALZF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CALZF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CALZF
Annual income on $10K today (after 15% tax)
$28,333.33/yr
After 10yr DRIP, annual income (after tax)
$1,663,627,971.90/yr
PEP
Annual income on $10K today (after 15% tax)
$308.41/yr
After 10yr DRIP, annual income (after tax)
$52,594.32/yr
At 15% tax rate, CALZF beats the other by $1,663,575,377.58/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CALZF + PEP for your $10,000?

CALZF: 50%PEP: 50%
100% PEP50/50100% CALZF
Portfolio after 10yr
$1556.19M
Annual income
$978,635,627.19/yr
Blended yield
62.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

CALZF
No analyst data
Altman Z
10.7
Piotroski
4/9
PEP
Analyst Ratings
1
Strong
15
Buy
27
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+10.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CALZF buys
0
PEP buys
0
No recent congressional trades found for CALZF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCALZFPEP
Forward yield333.33%3.63%
Annual dividend / share$2.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$3112.25M$141.9K
Annual income after 10y$1,957,209,378.70$61,875.67
Total dividends collected$3000.20M$123.0K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: CALZF vs PEP ($10,000, DRIP)

YearCALZF PortfolioCALZF Income/yrPEP PortfolioPEP Income/yrGap
1← crossover$44,033$33,333.33$10,849$509.42+$33.2KCALZF
2$184,291$137,175.49$11,969$750.47+$172.3KCALZF
3$733,748$536,556.79$13,500$1,124.14+$720.2KCALZF
4$2,781,635$1,996,524.01$15,680$1,721.66+$2.77MCALZF
5$10,050,002$7,073,652.70$18,929$2,715.34+$10.03MCALZF
6$34,638,543$23,885,041.43$24,023$4,450.80+$34.61MCALZF
7$114,000,322$76,937,080.16$32,510$7,669.92+$113.97MCALZF
8$358,625,914$236,645,569.53$47,709$14,093.60+$358.58MCALZF
9$1,079,474,884$695,745,156.26$77,415$28,083.48+$1079.40MCALZF
10$3,112,247,504$1,957,209,378.70$141,922$61,875.67+$3112.11MCALZF

CALZF vs PEP: Complete Analysis 2026

CALZFStock

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and tissue reinforcement products; NovoSorb Dermal Beta Cell Implant to host pancreatic islets in the skin; and NovoSorb drug elution depots. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Full CALZF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this CALZF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CALZF vs SCHDCALZF vs JEPICALZF vs OCALZF vs KOCALZF vs MAINCALZF vs MOCALZF vs PMCALZF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.